Effect of biologically synthesized gold nanoparticles on alloxan-induced diabetic rats-An in vivo approach

Colloids and Surfaces B: Biointerfaces

Volumn 122, Issue , 2014, Pages 505-511

  Karthick, V ^a   Kumar, V Ganesh ^a   Dhas, T Stalin ^a   Singaravelu, G ^c   Sadiq, A Mohamed ^b   Govindaraju, K ^a  

^a SATHYABAMA UNIVERSITY   (India)

^b Adhiparasakthi College of Arts and Science   (India)

^c THIRUVALLUVAR UNIVERSITY   (India)

Author keywords

Diabetes; Electron microscopy; Gold nanoparticles; Gymnema sylvestre; Hypoglycemia

Indexed keywords

ELECTRON MICROSCOPY;

ALLOXAN; DIABETIC RATS; GOLD NANOPARTICLES; GYMNEMA SYLVESTRE; HYPOGLYCEMIA; IN-VIVO;

MEDICAL PROBLEMS;

ALLOXAN; GLIBENCLAMIDE; GLUCOSE; GOLD NANOPARTICLE; GYMNEMA SYLVESTRE EXTRACT; GOLD; METAL NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; ELECTRON MICROSCOPY; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; MALE; MICROSCOPY; NANOFABRICATION; NONHUMAN; RAT; SPECTROSCOPY; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; ULTRAVIOLET SPECTROPHOTOMETRY; WISTAR RAT;

ALLOXAN; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GOLD; METAL NANOPARTICLES; MICROSCOPY, ATOMIC FORCE; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84909944201     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.07.022     Document Type: Article

References (51)

1. Liu Z., Li W., Li X., Zhang M., Chen L., Zheng Y., et al. Antidiabetic effects of malonyl ginsenosides from Panax ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin. J. Ethnopharmacol. 2013, 145:233-240.
2. Back S.H., Kaufman R.J. Endoplasmic reticulum stress and type 2 diabetes. Annu. Rev. Biochem. 2012, 81:767-793.
3. Venkatachalam M., Govindaraju K., Mohamed Sadiq A., Tamilselvan S., Ganesh Kumar V., Singaravelu G. Functionalization of gold nanoparticles as antidiabetic nanomaterial. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2013, 116:331-338.
4. Lautamaki R., Airaksinen K.E.J., Seppa M., Toikka J., Luotolahti M., Ball E., et al. Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease. Diabetes 2005, 54:2787-2794.
5. Tornio A., Niemi M., Neuvonen P.J., Backman J.T. Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends Pharmacol. Sci. 2012, 33:312-322.
6. Rajeswari A., Kumar V.G., Karthick V., Dhas T.S., Potluri S.L. Hydrothermal synthesis of hydroxyapatite plates prepared using low molecular weight heparin (LMWH). Colloid Surf. B Biointerf. 2013, 111:764-768.
7. 4 nanocomposite for multipurpose water purification application. RSC Adv. 2014, 4:28300-28308.
8. Arockiya Aarthi Rajathi F., Parthiban C., Ganesh Kumar V., Anantharaman P. Biosynthesis of antibacterial gold nanoparticles using brown alga, Stoechospermum marginatum (kützing). Spectrochim. Acta A Mol. Biomol. Spectrosc. 2012, 99:166-173.
9. Dhas T.S., Kumar V.G., Abraham L.S., Karthick V., Govindaraju K., Stalin Dhas T., et al. Sargassum myriocystum mediated biosynthesis of gold nanoparticles. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2012, 99:97-101.
10. Kumar V.G., Gokavarapu S.D., Rajeswari A., Dhas T.S., Karthick V., Kapadia Z., et al. Facile green synthesis of gold nanoparticles using leaf extract of antidiabetic potent Cassia auriculata. Colloid Surf. B Biointerf. 2011, 87:159-163.
11. Nirmala Grace A., Pandian K. One pot synthesis of polymer protected Pt, Pd, Ag and Ru nanoparticles and nanoprisms under reflux and microwave mode of heating in glycerol-a comparative study. Mater. Chem. Phys. 2007, 104:191-198.
12. Shanmugasundaram K.R., Panneerselvam C., Samudram P., Shanmugasundaram B.E.R. The insulinotropic activity of Gymnema sylvestre, R.Br. an indian medical herb used in controlling Diabetes mellitus. Pharmacol. Res. Commun. 1981, 475-486.
13. Baskaran K., Ahamath B.K., Shanmugasundaram K., Radha E.R., Shanmugasundaram Antidibetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependant diabetes mellitus patients. J. Ethnopharmacol. 1990, 30:295-305.
14. Kanetkar P., Singhal R., Kamat M. Gymnema sylvestre: a memoir. J. Clin. Biochem. Nutr. 2007, 41:77-81.
15. Daisy P., Eliza J., Mohamed Farook K.A.M. A novel dihydroxy gymnemic triacetate isolated from Gymnema sylvestre possessing normoglycemic and hypolipidemic activity on STZ-induced diabetic rats. J. Ethnopharmacol. 2009, 126:339-344.
16. Pari L., Satheesh M.A. Antidiabetic activity of Boerhaavia diffusa L.: effect on hepatic key enzymes in experimental diabetes. J. Ethnopharmacol. 2004, 91:109-113.
17. Pari L., Maheswari J.U. Hypoglycaemic effect of Musa sapientum L. in alloxan-induced diabetic rats. J. Ethnopharmacol. 1999, 68:321-325.
18. Mulvaney P. Surface plasmon spectroscopy of nanosized metal particles. Langmuir 1996, 12:788-800.
19. Govindaraju K., Basha S.K., Kumar V.G., Singaravelu G. Silver, gold and bimetallic nanoparticles production using single-cell protein (Spirulina platensis) Geitler. J. Mater. Sci. 2008, 43:5115-5122.
20. Philip D. Synthesis and spectroscopic characterization of gold nanoparticles. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2008, 71:80-85.
21. Karthick V., Kumar V.G., Dhas T.S., Govindaraju K., Sinha S., Singaravelu G. Biosynthesis of gold nanoparticles and identification of capping agent using gas chromatography-mass spectroscopy and matrix assisted laser desorption ionization-mass spectrometry. J. Nanosci. Nanotechnol. 2014, 14:1-6.
22. Karthick V., Ganesh Kumar V., Maiyalagan T., Deepa R., Govindaraju K., Rajeswari A., et al. Green synthesis of well dispersed nanoparticles using leaf extract of medicinally useful adhatoda vasica nees. Micro Nanosyst. 2012, 4:192-198.
23. Vasanth K., Ilango K., Mohankumar R., Agrawal A., Dubey G.P. Anticancer activity of Moringa oleifera mediated silver nanoparticles on human cervical carcinoma cells by apoptosis induction. Colloid Surf. B Biointerf. 2014, 117:354-359.
24. Mocanu A., Cernica I., Tomoaia G., Bobos L.-D., Horovitz O., Tomoaia-Cotisel M. Self-assembly characteristics of gold nanoparticles in the presence of cysteine. Colloid Surf. A Physicochem. Eng. Asp. 2009, 338:93-101.
25. Mohanty R.K., Thennarasu S., Mandal A.B. Resveratrol stabilized gold nanoparticles enable surface loading of doxorubicin and anticancer activity. Colloid Surf. B Biointerf. 2014, 114:138-143.
26. Plascencia-Villa G., Bahena D., Rodríguez A.R., Ponce A., Jose-Yacaman M. Advanced microscopy of star-shaped gold nanoparticles and their adsorption-uptake by macrophages. Metallomics 2013, 5:242-250.
27. Yamamoto H., Uchigata Y., Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 1981, 294:284-286.
28. P.S., Shanmugasundaram E.R.B.S.K.R., Panneerselvam C. Enzyme changes and glucose utilisation in diabetic rabbits: the effect of Gymnema sylvestre R. Br. J. Ethnopharmocol. 1983, 7:205-234.
29. Shanmugasundaram E.R.B., Rajeswari G., Baskaran K., Kumar B.R., Shanmugasundaram K.R., Ahmath B.K. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependant diabetes mellitus. J. Ethnopharmacol. 1990, 30:281-294.
30. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 1984, 101:527-537.
31. Lutz T.A., Woods S.C. Overview of animal models of obesity. Curr. Protoc. Pharmacol. 2012, 5.61:1-22.
32. Shanmugasundaram E.R.B., Gopinath K.L., Shanmugasundaram K.R., Rajendran V.M. Possible regeneration of the islets of langerhans In streptozotocin-diabetic Rats given Gymnema sylvestre leaf extracts. J. Ethnopharmocol. 1990, 30:265-279.
33. Bunn H.F. Evaluation of glycosylated hemoglobin in diabetic patients. Diabetes 1981, 30:613-617.
34. Fluckiger R., Woodtli T., Berger W. Quantitation of glycosylated hemoglobin by boronate affinity chromatography. Diabetes 1984, 33:73-76.
35. Karthikesan K., Pari L., Menon V.P. Chemico-biological interactions antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents. Chem. Biol. Interact. 2010, 188:643-650.
36. Kayal R.A., Siqueira M., Alblowi J., McLean J., Krothapalli N., Faibish D., et al. TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J. Bone Miner. Res. 2010, 25:1604-1615.
37. Ndumele C.E., Pradhan A.D., Ridker P.M. Interrelationships between inflammation, C-reactive protein, and insulin resistance. J. Cardiometab. Syndr. 2006, 1:190-196.
38. Gylling H., Miettinen T.A. Cholesterol absorption, synthesis, and LDL metabolism in NIDDM. Diabetes Care 1997, 20:90-95.
39. Boden G., Shulman G.I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Invest. 2002, 32(Suppl. 3):14-23.
40. Study C., Diabetogenic T., Alloxan A. Comparative study of early metabolic events resulting from the administration of the two diabetogenic agents alloxan and streptozotocin. Eur. J. Clin. Invest. 1970, 1:104-108.
41. Shaik A.H., Rasool S.N., Vikram Kumar Reddy A., Abdul Kareem M., Saayi Krushna G., Lakshmi Devi K. Cardioprotective effect of HPLC standardized ethanolic extract of Terminalia pallida fruits against isoproterenol-induced myocardial infarction in albino rats. J. Ethnopharmacol. 2012, 141:33-40.
42. Shigematsu N., Asano R., Shimosaka M., Okazaki M. Effect of administration with the extract of Gymnema sylvestre R. Br leaves on lipid metabolism in rats. Biol. Pharm. Bull. 2001, 24:713-717.
43. Christen U., Wolfe T., Möhrle U., Hughes A.C., Rodrigo E., Green E.A., et al. A dual role for TNF-α in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 2013, 166:7023-7032.
44. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 2000, 106:171-176.
45. Kushner I. Regulation of the acute phase response by cytokines. Perspect. Biol. Med. 1993, 36:611-622.
46. Rifai N., Ridker P.M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem. 2001, 47:403-411.
47. Wang Y., Xiao Z., Liu S., Wan L., Yue Y., Zhang Y., et al. Antidiabetic effects of Swertia macrosperma extracts in diabetic rats. J. Ethnopharmacol. 2013, 150:536-544.
48. Levy R.H., Thummel K.E., Trager W.F., Hansten P.D., Eichelbaum M. Metabolic Drug Interactions 2000, Lippincott Williams & Wilkins.
49. Hsiang B., Zhu Y., Wang Z., Wu Y., Sasseville V., Yang W.-P., et al. A novel human hepatic organic anion transporting polypeptide (OATP2): identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J. Biol. Chem. 1999, 274:37161-37168.
50. Davda J., Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm. 2002, 233:51-59.
51. Govindaraju K., Kiruthiga V., Kumar V.G., Singaravelu G. Extracellular synthesis of silver nanoparticles by a marine alga, Sargassum wightii Grevilli and their antibacterial effects. J. Nanosci. Nanotechnol. 2009, 9:5497-5501.